On 30th April, FAMHP published V2 of the Addendum to the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic

Please note that this document is to be read in conjunction with the latest version of the European guidance and that the national guidance provides some more detailed clarifications and additional topics of interest. This text was written by the FAMHP, the Clinical Trial College and the Belgian association of Research Ethics Committees (BAREC).
The information in this guidance can be applied from the moment of publication until there is a new version.
The situation is evolving rapidly and further updates to this guidance are therefore expected.

https://www.fagg.be/sites/default/files/content/national_guidance_corona_20200429c_clean.pdf

Need more information ?

BECRO

PLACE MARCEL BROODTHAERS PLEIN, 8 BOX 5
B-1060 BRUSSELS / BELGIUM
PHONE: +32 (0)2 892 40 00
E-MAIL: INFO@BECRO.BE

© 2018 BECRO – ALL RIGHTS RESERVED

Octopix + WordPress = ♥ | Design by Simplexity